We are live on ! Find out more
SIIG

SC Israel IV Genpar Portfolio holdings

AUM $17.5M
This Fund
S&P 500
This Quarter Est. Return
+63.25%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$48M
AUM Growth
+$18.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTV
1
DELISTED
Innovid Corp.
CTV
$48M 100%
17,697,224
– –

Similar funds

RPA
Rose Park Advisors Boston, Massachusetts $17.5M AUM 44.41% 1-Year Est. Return
UID
Union Investments & Development Tel Aviv, Israel $17.3M AUM 20.08% 1-Year Est. Return
TOTSC
Trustees of the Smith College Northampton, Massachusetts $18.3M AUM 20.14% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
OCM
Oakview Capital Management Dallas, Texas $21.6M AUM 20.25% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

SC Israel IV Genpar's Q3 2022 Portfolio in Review

As of Q3 2022, SC Israel IV Genpar held 1 position worth $48M, up 63% from $29.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. SC Israel IV Genpar opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 100% of assets, unchanged from a quarter earlier.

  • SC Israel IV Genpar's ten largest holdings make up 100% of its $48M portfolio in Q3 2022.
  • SC Israel IV Genpar opened 0 new positions and closed 0 in Q3 2022.
  • SC Israel IV Genpar's portfolio value rose 63% quarter-over-quarter to $48M.

Based on SC Israel IV Genpar's 13F filing for Q3 2022, filed 14 Nov 2022.